BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Chemotherapy-Induced Thrombocytopenia readouts · AssetMemo
X-WR-CALDESC:Upcoming phase 1/2 and later readouts in Chemotherapy-Induced 
 Thrombocytopenia\, from ClinicalTrials.gov estimates.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07408648-11067@assetmemo.bio
DTSTAMP:20261121T005024Z
DTSTART;VALUE=DATE:20270415
DTEND;VALUE=DATE:20270416
SUMMARY:Hetrombopag: Phase 2 readout est. (NCT07408648)
DESCRIPTION:Hetrombopag\, phase 2\, Chemotherapy-Induced Thrombocytopenia.\
 nStudy: A Clinical Study on the Efficacy and Safety of Hetrombopag in the 
 Treatment of Thrombocytopenia Induced by Gynecological Tumor Therapy\nEsti
 mated primary completion: 15 April 2027. This is a ClinicalTrials.gov esti
 mate\, not a confirmed readout date\, and it can move.\nDrug page: https:/
 /assetmemo.bio/drug/hetrombopag#upcoming-events\nRegistry record: https://
 clinicaltrials.gov/study/NCT07408648
URL:https://assetmemo.bio/drug/hetrombopag#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT07243418-11067@assetmemo.bio
DTSTAMP:20261121T005024Z
DTSTART;VALUE=DATE:20271130
DTEND;VALUE=DATE:20271201
SUMMARY:Hetrombopag: Phase 2 readout est. (NCT07243418)
DESCRIPTION:Hetrombopag\, phase 2\, Chemotherapy-Induced Thrombocytopenia.\
 nStudy: Hetrombopag for the Prevention of ADC-Induced Thrombocytopenia in 
 Breast Cancer: An Exploratory\, Dual-Cohort\, Phase 2 Study\nEstimated pri
 mary completion: 30 November 2027. This is a ClinicalTrials.gov estimate\,
  not a confirmed readout date\, and it can move.\nDrug page: https://asset
 memo.bio/drug/hetrombopag#upcoming-events\nRegistry record: https://clinic
 altrials.gov/study/NCT07243418
URL:https://assetmemo.bio/drug/hetrombopag#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT07647029-11067@assetmemo.bio
DTSTAMP:20261121T005024Z
DTSTART;VALUE=DATE:20280229
DTEND;VALUE=DATE:20280301
SUMMARY:Hetrombopag: Phase 2 readout est. (NCT07647029)
DESCRIPTION:Hetrombopag\, phase 2\, Chemotherapy-Induced Thrombocytopenia.\
 nStudy: A Clinical Study on Prophylactic RespOnse To hEtrombopag for Secon
 dary Prevention in Anti-Cancer Therapy-induced Thrombocytopeniae\nEstimate
 d primary completion: 29 February 2028. This is a ClinicalTrials.gov estim
 ate\, not a confirmed readout date\, and it can move.\nDrug page: https://
 assetmemo.bio/drug/hetrombopag#upcoming-events\nRegistry record: https://c
 linicaltrials.gov/study/NCT07647029
URL:https://assetmemo.bio/drug/hetrombopag#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT07252375-11067@assetmemo.bio
DTSTAMP:20261121T005024Z
DTSTART;VALUE=DATE:20280530
DTEND;VALUE=DATE:20280531
SUMMARY:Hetrombopag: Phase 2 readout est. (NCT07252375)
DESCRIPTION:Hetrombopag\, phase 2\, Chemotherapy-Induced Thrombocytopenia.\
 nStudy: A Clinical Study of Hetrombopag for Prevention of Thrombocytopenia
  Induced by Gemcitabine Plus Cisplatin in the Treatment of Nasopharyngeal 
 Carcinoma\nEstimated primary completion: 30 May 2028. This is a ClinicalTr
 ials.gov estimate\, not a confirmed readout date\, and it can move.\nDrug 
 page: https://assetmemo.bio/drug/hetrombopag#upcoming-events\nRegistry rec
 ord: https://clinicaltrials.gov/study/NCT07252375
URL:https://assetmemo.bio/drug/hetrombopag#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT07286032-11067@assetmemo.bio
DTSTAMP:20261121T005024Z
DTSTART;VALUE=DATE:20281231
DTEND;VALUE=DATE:20290101
SUMMARY:Hetrombopag: Phase 3 readout est. (NCT07286032)
DESCRIPTION:Hetrombopag\, phase 3\, Chemotherapy-Induced Thrombocytopenia.\
 nStudy: A Study to Evaluate the Efficacy and Safety of Hetrombopag Olamine
  Tablets Vs Placebo in Patients With Chemotherapy-Induced Thrombocytopenia
  (ExCIT)\nEstimated primary completion: December 2028. This is a ClinicalT
 rials.gov estimate\, not a confirmed readout date\, and it can move.\nDrug
  page: https://assetmemo.bio/drug/hetrombopag#upcoming-events\nRegistry re
 cord: https://clinicaltrials.gov/study/NCT07286032
URL:https://assetmemo.bio/drug/hetrombopag#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
